Reduced Progesterone Metabolites in Human Late Pregnancy
Total Page:16
File Type:pdf, Size:1020Kb
Physiol. Res. 60: 225-241, 2011 https://doi.org/10.33549/physiolres.932077 REVIEW Reduced Progesterone Metabolites in Human Late Pregnancy M. HILL1,2, A. PAŘÍZEK2, R. KANCHEVA1, J. E. JIRÁSEK3 1,2Institute of Endocrinology, Prague, Czech Republic, 2Department of Obstetrics and Gynecology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic, 3Department of Clinical Biochemistry and Laboratory Diagnostics of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic Received November 20, 2010 Accepted November 25, 2010 On-line November 29, 2010 Summary Corresponding author In this review, we focused on the intersection between steroid A. Pařízek, Department of Obstetrics and Gynecology of the metabolomics, obstetrics and steroid neurophysiology to give a First Faculty of Medicine and General Teaching Hospital, comprehensive insight into the role of sex hormones and Apolinářská 18, 128 51 Prague 2, Czech Republic. E-mail: neuroactive steroids (NAS) in the mechanism controlling [email protected] pregnancy sustaining. The data in the literature including our studies show that there is a complex mechanism providing synthesis of either pregnancy sustaining or parturition provoking Introduction steroids. This mechanism includes the boosting placental synthesis of CRH with approaching parturition inducing the Although the effects of neuroactive and excessive synthesis of 3β-hydroxy-5-ene steroid sulfates serving neuroprotective 5α/β-reduced progesterone metabolites primarily as precursors for placental synthesis of progestogens, were extensively studied, the physiological relevance of estrogens and NAS. The distribution and changing activities of these substances remains frequently uncertain due to the placental oxidoreductases are responsible for the activation or lack of metabolomic data. We attempted to elucidate the inactivation of the aforementioned steroids, which is role of sex hormones and neuroactive steroids (NAS) in compartment-specific (maternal and fetal compartments) and the mechanism controlling the pregnancy maintenance dependent on gestational age, with a tendency to shift the and parturition onset. production from the pregnancy-sustaining steroids to the parturition provoking ones with an increasing gestational age. Biosynthesis of neuroactive steroids in The fetal and maternal livers catabolize part of the bioactive human pregnancy steroids and also convert some precursors to bioactive steroids. Besides the progesterone, a variety of its 5α/β-reduced Steroid metabolism in fetal and maternal adrenal metabolites may significantly influence the maintenance of human pregnancy, provide protection against excitotoxicity Placental CRH regulate the steroid biosynthesis in following acute hypoxic stress, and might also affect the pain pregnancy perception in mother and fetus. The machinery regulating production of pregnancy steroids is based on the excessive placental Key words production of corticoliberin (CRH) (Fig. 1) (Goland et al. Neuroactive steroids • Pregnancy • Plasma • Metabolome • 1986, Rainey et al. 2004, Smith et al. 2009). Pregnant GC-MS women after luteo-placental shift produce CRH primarily in the placenta and instead of the negative feedback loop PHYSIOLOGICAL RESEARCH • ISSN 0862-8408 (print) • ISSN 1802-9973 (online) © 2011 Institute of Physiology v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic Fax +420 241 062 164, e-mail: [email protected], www.biomed.cas.cz/physiolres 226 Hill et al. Vol. 60 Fig. 1. Simplified scheme of steroidogenesis in pregnancy. cortisol-ACTH-CRH; there is a positive one between Steroid metabolism in fetal and maternal liver cortisol and CRH, while the ACTH production stagnates. The rising CRH levels in the last four weeks of C-3, C-17 and C-20 oxidoreductive conversions pregnancy stimulate the synthesis of conjugated Δ5 The enzymes, catalyzing reversible C-3, C-17 and steroids in the fetal adrenal (Smith et al. 1998, Sirianni et C-20 oxidoreductive inter-conversions belong to either the al. 2005). CRH is as effective as ACTH at stimulating short-chain dehydrogenases/reductases (SDRs) or the aldo- sulfated dehydroepiandrosterone (DHEAS) production keto reductases (AKRs). Human liver contains various but is 70 % less potent than ACTH at stimulating cortisol isoforms of AKRs (AKR1C1, AKR1C2, AKR1C3, and production. The excessive production of placental CRH is AKR1C4) with 20α-, 17β-, 3α- or 3β-hydroxysteroid specific for primates and the boosting CRH production dehydrogenase-like activity (Shiraishi et al. 1998, Penning near term is specific only for humans and great apes et al. 2001, Jin et al. 2009). AKRs activities could control 5 (Power and Schulkin 2006). The sulfated Δ steroids, occupancy of the androgen- and GABAA-receptors originating in the fetal zone of the fetal adrenal (FZ), (Penning 1999) via reduction of oxo-groups mostly in the represent the largest fraction of steroids in pregnancy steroid C3 and C17 positions, respectively. In vivo, all (Ingelman-Sundberg et al. 1975, Lacroix et al. 1997, AKR1Cs preferentially work as reductases (Steckelbroeck Moghrabi et al. 1997, Leeder et al. 2005). The FZ is et al. 2004) and are capable to reduce estrone, similar to the adult zona reticularis but unlike the adult progesterone, and 3-oxo-pregnane/androstane steroids to zona reticularis, the FZ produces excessive amounts of estradiol, 20α-dihydroprogesterone, and GABAergic sulfated C-21 Δ5 steroids, including sulfates of 3α-hydroxy-5α/β-pregnane/androstane steroids, respecti- pregnenolone and 17-hydroxypregnenolone (Rainey et al. vely. On the other hand, AKR1Cs may decrease the 2004, Hill et al. 2010a,b). These substances serve as concentrations of GABAergic steroids by inactivating precursors for the placental production of estradiol (Smith allopregnanolone and eliminating the precursors like et al. 1998, Sirianni et al. 2005) and progesterone (Jaffe progesterone from the synthetic pathways via reduction of and Ledger 1966, Komatsuzaki et al. 1987, Walsh 1988, the 20-oxo-steroid group (Penning et al. 2000, Usami et al. Hill et al. 2010b). 2002). The AKR1C2 preferring 3α-reduction over the 3β- reduction may catalyze 3α-, 17β-, and 20α-hydroxysteroid 2011 Neuroactive Steroids in Late Pregnancy 227 dehydrogenase (HSD) reactions (HSD) (Penning et al. the highest levels in the liver. SRD5A1 converts 2000, Jin et al. 2001, 2009, Usami et al. 2002). AKR1C3 testosterone into 5α-dihydrotestosterone and progesterone catalyzes the reduction of 5α-dihydrotestosterone or corticosterone to their 5α-reduced counterparts. In the (5α-DHT), androstenedione, estrone and progesterone to peripheral tissues, including the liver, SRD5A1 and produce 5α-androstan-3α,17β-diol, testosterone, estradiol reductive 3α-HSD isoforms work consecutively and 20α-dihydroprogesterone, respectively (Penning et al. eliminating the androgens, protecting against the 2001). AKR1C4, the expression of which is specific for the hormone excess (Jin and Penning 2001) and producing liver (Nishizawa et al. 2000, Penning et al. 2000, 2004), GABAergic steroids, which are, however, extensively catalyzes the transformation of the 5α-DHT into sulfated in the liver. Liver 5β-reductase (AKR1D1) 5α-androstan-3α,17β-diol. Liver specific AKR1C4 shows belonging to AKRs, efficiently catalyzes the reduction of superior catalytic efficiency exceeding those obtained with both C-19 and C-21 3-oxo-Δ4 steroids to the the other isoforms by 10-30-fold. In contrast to the other corresponding 5β-reduced metabolites (Kochakian 1983, isoforms, the catalytic efficiency for AKR1C4 is Okuda and Okuda 1984). unaffected by steroid conjugation (Jin et al. 2009). From The higher levels of 5β-reduced progesterone the SDRs, the type 7 17β-HSD (HSD17B7), preferring the metabolites in the fetus than in maternal compartment, as reduction of the oxo-groups in 20-, 17- and 3-positions to well as the arteriovenous differences in the fetus indicate the corresponding 20α-hydroxy-, 17β-hydroxy-, and that steroid 5α/β-reductions in the fetal liver and not in 3α-hydroxy-counterparts, is also significantly expressed in the placenta are important for production of GABAergic the liver (Krazeisen et al. 1999, Torn et al. 2003) as well as 5α/β-reduced NAS in both maternal and fetal type 12 17β-HSD (HSD17B12) catalyzing the transfor- compartments (Hill et al. 2010a). mation of estrone into the estradiol (Sakurai et al. 2006). On the other hand, type 2 17β-HSD (HSD17B2), Steroid metabolism in placenta type 10 17β-HSD (HSD17B10) and type 11 17β-HSD (HSD17B11), which are also highly expressed in the liver, Steroid sulfatases and placental production of sex prefer the oxidative direction. HSD17B2 may contribute to hormones formation of 20-oxo- and 17-oxo-steroids from their 20α- The principal metabolic step that is and 17β- counterparts (Moghrabi et al. 1997). Type 6 indispensable for further placental metabolism of sulfated 17β-HSD (HSD17B6) prefers oxidoreductase and Δ5 steroids originating in FZ is their desulfation, which is 3(α→β)-hydroxysteroid epimerase activities and acts on catalyzed by the placental STS. Placental STS activity is both C-19 and C-21 3α-hydroxysteroids (Huang and Luu- independent of substrate concentration (Watanabe et al. The 2000). HSD17B10 being abundantly expressed in the 1990) and of gestational age (GA) (Ishida et al. 1985, liver, is capable of catalyzing the oxidation of steroid Fukuda et al. 1986, Leslie et al. 1994). The placental STS modulators of GABAA-r